Shaw, Michael (2006) Hyperprolactinaemia and Antipsychotic Drug Use : The Benefits of Prolactin Screening for Mental Health Patients. Mental Health and Learning Disabilities Research and Practice, 3 (1). pp. 87-98. ISSN 1743-6885
|PDF - Published Version |
Download (505kB) | Preview
Hyperprolactinaemia is associated with drugs used in the field of Mental Health to treat psychosis (antipsychotic).
This has been found to be affecting a significant number of service users taking this medication. Hyperprolactinaemia causes endocrine disturbances including sexual dysfunction and amenorrhea and infertility. However, in the longer term service users are at risk of some disabling conditions such as osteoporosis.
As part of our ongoing medication management work, early detection of hyperprolactinaemia enables safer use of antipsychotic drugs.
|Subjects:||R Medicine > R Medicine (General)|
R Medicine > RS Pharmacy and materia medica
|Depositing User:||Cherry Edmunds|
|Date Deposited:||05 Jan 2012 12:12|
|Last Modified:||16 Aug 2013 13:20|
Downloads per month over past year
Repository Staff Only: item control page